Kennel club
Kennel club
The capital market and health care environments are putting a premium on the ability of biotech companies to rethink their business strategies to fit the times. Except for a lucky few, companies of the class of '91-92 that grew up with the fully integrated biopharmaceutical company (Fibco) model risk being left behind.
One company that isn't waiting is Glycomed Inc., which on Friday